Multiple trials and studies are underway to examine the possibility to
use gene therapy to replace the defective genes in hemophilia. To date,
stable and sustained production of the deficient clotting factors has
not been achieved in humans, but this is an area of active investigation
that holds great promise for the future.
Random Posts
SPORTS
DAILY HACKS
EDUCATION
‹
›
HEALTH
MAKE MONEY ONLINE
News
TRAVEL
Subscribe to:
Post Comments (Atom)
No comments